Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03177616 · ClinicalTrials.gov registry record · NA
Integrative Migraine Pain Alleviation Through Chiropractic Therapy
A NA study of Migraine and Migraine Disorders, sponsored by Harvard University Faculty of Medicine.
- Completed
- Registry status
- NA
- Development phase
- 61
- Enrollment target
- 1
- Study location
NCT03177616: Completed NA study of Migraine and Migraine Disorders, sponsored by Harvard University Faculty of Medicine.
NCT03177616 is a NA study of Migraine and Migraine Disorders that has completed, run by Harvard University Faculty of Medicine. The registered enrollment target is 61 participants, below the 358-participant average among 102 other Migraine trials with a reported enrollment target (83% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03177616, a NA study of Migraine and Migraine Disorders, has completed, sponsored by Harvard University Faculty of Medicine.
- COMPLETED
- Registry status
- NA
- Development phase
- 61 participants
- Enrollment target
- 1
- Study location
Study Summary
This pilot study evaluates the addition of chiropractic treatment to conventional neurological care in the treatment of migraine headaches in adult women. Half of the participants will receive 10 chiropractic treatments in addition to their usual care over a 14 week period, while the other half will continue their usual medical care alone, as prescribed by their physician during that time period.
Primary Outcome
Participants will record number of migraines experienced in provided logs.
Conditions Studied
Interventions
- OTHER Chiropractic Treatment
Study Locations (1)
Massachusetts
- The Osher Clinical Center for Integrative Medicine at Brigham and Women's Hospital - Boston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 61 participants |
| Start Date | 2017-06-07 |
| Est. Completion | 2022-11-04 |
| Phase | NA |
What the finished NCT03177616 record still lists
NCT03177616 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 61 participants, a relatively small participant target, below the 358-participant average among 102 other Migraine trials with a reported enrollment target (83% lower).
The record links to 5 conditions, with Migraine appearing as the primary indexed condition, and to 1 intervention - of which Chiropractic Treatment is the first listed.
NCT03177616 reports a single indexed study location in Massachusetts.
Frequently Asked Questions
What is clinical trial NCT03177616 about?
NCT03177616 is a clinical study titled "Integrative Migraine Pain Alleviation Through Chiropractic Therapy". This pilot study evaluates the addition of chiropractic treatment to conventional neurological care in the treatment of migraine headaches in adult women. Half of the participants will receive 10 chiropractic treatments in addition to their usual care over a 14 week period, while the other half will...
What is the current status of trial NCT03177616?
This trial is currently completed. It is a NA study. The enrollment target is 61 participants. The study started on 2017-06-07. Estimated completion is 2022-11-04.
What conditions does trial NCT03177616 study?
This clinical trial studies the following conditions: Migraine, Migraine Disorders, Migraine With Aura, Migraine Without Aura, Migraine, Classic.
What interventions are being tested in trial NCT03177616?
The interventions under investigation include: Chiropractic Treatment (OTHER).
Who is sponsoring clinical trial NCT03177616?
This trial is sponsored by Harvard University Faculty of Medicine, which has 9 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03177616 being conducted?
This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Migraine
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT03177616's enrollment target sits among peer trials
61 73rd of 102 higher than 30 of 102 other Migraine trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Migraine trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
MMA Embolization for Refractory Chronic Migraine
RECRUITING · NA
-
Stimulation of External Carotid Artery Circulation
RECRUITING · NA
-
Responding With Evidence and Access for Childhood Headaches
RECRUITING · NA
-
Determining the Utility of a Behavioral Intervention in Chronic Migraine
RECRUITING · NA
-
Cocoa Extract for Migraine Trial
RECRUITING · NA
-
Migraine in Adolescents
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04115306 · 61 participants · Phase 1
Phase 1/1b/2 Study of Oral PMD-026 in Patients With Metastatic Breast Cancer
- NCT05070845 · 61 participants · Phase 2
Safety and Efficacy Study of PF-06835375 in Primary Immune Thrombocytopenia
- NCT05187832 · 61 participants · Phase 1
A Study of AND019 in Women With ER Positive HER2 Negative Advanced or Metastatic Breast Cancer
- NCT05269316 · 61 participants · Phase 1
Study to Evaluate IMP9064 as a Monotherapy or in Combination in Patients With Advanced Solid Tumors
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI